The Increasing Medication Access for Seniors Act of 2025 requires the Secretary of Health and Human Services to submit a report to Congress on the option to pay prescription drug plan or MA-PD cost-sharing in monthly capped amounts. The report must be produced not later than three months after enactment, with subsequent updates at least every three months for the first year and then annually through March 31, 2031.
The bill also defines key terms and directs what data, methods, and outreach the Secretary must describe in the report. The intent is to establish a baseline understanding of uptake, potential beneficiaries, and practical pathways to implement such an option, without mandating immediate adoption.
At a Glance
What It Does
It requires the Secretary to produce a series of reports detailing uptake, regional and plan-type breakdowns, potential beneficiaries, and implementation mechanisms for monthly cap cost-sharing under Part D.
Who It Affects
Medicare Part D enrollees (in PDP and MA-PD plans), Part D sponsors, healthcare providers, pharmacies, and patient advocacy groups who would use or be affected by any shift toward monthly cap cost-sharing.
Why It Matters
The data and analysis will inform policymakers about feasibility, demand, and the design considerations needed to reduce unpredictable out-of-pocket costs for seniors.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The act channels a data-driven look at whether a monthly cap on Part D cost-sharing could improve predictability for seniors who depend on prescription drug coverage. It does not implement a cap itself; instead, it requires the Department of Health and Human Services to report on the option and how it might be offered at the point of sale.
The report must cover who has elected the option (and where they live, by Census region), how many enrollees would benefit but did not elect, and the practical steps to enable a sale-point election. It also requires describing the tools and outreach channels used to inform beneficiaries and providers about the option, such as Medicare.gov, the Medicare & You handbook, and the 1-800-MEDICARE line, as well as engagement with provider associations, patient groups, PBMs, pharmacies, and insurers.
Finally, the definitions section clarifies who counts as a Medicare Part D enrollee and what terms like “covered Part D drug,” “prescription drug plan,” and “MA-PD plan” mean for the purposes of the report.
The Five Things You Need to Know
The Secretary must report on the monthly cap cost-sharing option under 1860D-2(b)(2)(E)(i).
Reports are due not later than 3 months after enactment, then quarterly for 1 year, then annually through March 31, 2031.
The data must include regional and plan-type breakdowns of enrollees who elect the option.
The Secretary must estimate how many enrollees did not elect but would benefit from the option.
The Secretary must describe implementation mechanisms at point-of-sale and outreach methods (Medicare.gov, Medicare handbook, 1-800-MEDICARE, providers, PBMs, pharmacies, insurers).
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
This act may be cited as the Increasing Medication Access for Seniors Act of 2025. It establishes the purpose and framing for a data-driven review of a monthly cap cost-sharing option within Medicare Part D and MA-PD plans.
Reports on Monthly Cap Cost-Sharing Option
Not later than three months after enactment, the Secretary must submit a report to Congress on the option to pay cost-sharing under a prescription drug plan or MA–PD plan in monthly capped amounts. The report must be updated not less frequently than every three months for the first year, and annually thereafter through March 31, 2031. It must include, for the year preceding each report, the number of Medicare Part D enrollees who elected the option, with breakdowns by Census region, and by whether they are in a prescription drug plan or an MA–PD plan.
Continued Reporting Requirements
The Secretary must also estimate how many Part D enrollees did not elect the option and incurred out-of-pocket costs likely to be reduced by the option, and describe steps taken to implement an at-the-point-of-sale election mechanism and how such a mechanism could be available to all Part D enrollees. The section also requires detailing the methods used to facilitate elections, including Medicare.gov, the Medicare & You handbook, the 1-800-MEDICARE line, and provider resources, plus other outreach efforts.
Definitions
Definitions determine who qualifies as a Medicare Part D enrollee and clarify terms used in the report, including ‘Medicare Part D enrollee,’ ‘covered Part D drug,’ ‘prescription drug plan,’ and ‘MA–PD plan,’ all with meanings drawn from the Social Security Act. These definitions ensure consistent interpretation across reports and analysis.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Medicare Part D enrollees who elect the monthly cap option benefit from predictable, capped cost-sharing and budgeting clarity.
- Seniors with high annual out-of-pocket costs may see potential relief if the option becomes available.
- Medicare Part D plans (PDP and MA-PD) gain clear, data-driven information to tailor member outreach and support services.
- Health care providers and pharmacies can better assist seniors through standardized information and outreach channels.
- Patient advocacy groups focused on seniors gain access to CMS data for targeted advocacy and education.
Who Bears the Cost
- CMS/HHS will incur administrative costs to implement, collect, and publish the required reports and data analyses.
- Medicare Part D sponsors may bear incremental administrative burdens to compile and verify data for the reports.
- Pharmacies, PBMs, and provider networks may incur costs to participate in outreach and to align point-of-sale messaging with reported guidance.
- The broader health system may bear opportunity costs if resources are diverted to reporting rather than direct care efforts.
Key Issues
The Core Tension
The central tension is between gathering enough, high-quality data to assess the potential value of monthly cap cost-sharing and the practical burden this imposes on CMS, plans, providers, and beneficiaries, without committing to immediate adoption or requiring costly systemic changes before the data proves value.
The bill creates a robust data-collection regime to inform a possible future policy on monthly cap cost-sharing, but it stops short of mandating the cap itself. The frequency and scope of reporting could impose ongoing administrative workload and data-management challenges for CMS, especially in the early years.
The effectiveness of the mechanism depends on clear, implementable steps at the point of sale and on durable access to outreach channels across diverse beneficiaries. Privacy, data accuracy, and cross-system integration (Medicare.gov, handbooks, helplines, and provider networks) will shape how useful the reports are in practice.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.